中国中免：股票交易异常波动

Core Viewpoint - The stock of China National Pharmaceutical Group (China National Immunization) experienced a significant price fluctuation, with a cumulative increase of over 20% in three consecutive trading days, prompting an announcement regarding the abnormal trading situation [1] Summary by Relevant Sections - Stock Price Movement - The company's A-share stock price rose by more than 20% over three consecutive trading days on November 7, 10, and 11, 2025, indicating abnormal trading activity [1] - Company's Response - Following the price fluctuation, the company conducted a self-examination and confirmed that there are no undisclosed significant matters or risks as of the announcement date [1] - Operational Status - The company's daily operations are reported to be normal and orderly, with no significant changes occurring [1] - Disclosure of Information - The company and its controlling shareholder have not identified any undisclosed significant information related to major asset restructuring, share issuance, significant transactions, debt restructuring, business restructuring, share buybacks, equity incentives, bankruptcy reorganization, major business cooperation, or introduction of strategic investors [1] - Market Influence - There have been no media reports or market rumors that could potentially impact the company's stock trading price, nor does it involve any trending concepts [1] - Insider Trading - During the period of abnormal stock price fluctuation, the company's directors, supervisors, senior management, and controlling shareholders did not engage in buying or selling the company's stock [1]